OMX Nordic 40
2.437,72
PKT
+25,37
PKT
+1,05
%
Werbung
Analysen zu OMX Nordic 40-Werten
| Datum | Rating | Analyst | |
|---|---|---|---|
| 23.10.17 | ABB (Asea Brown Boveri) Neutral | JP Morgan Chase & Co. | |
| 23.10.17 | Nokia overweight | JP Morgan Chase & Co. | |
| 23.10.17 | Volvo (B) buy | Citigroup Corp. | |
| 20.10.17 | Novo Nordisk Equal-Weight | Morgan Stanley | |
| 20.10.17 | AstraZeneca Equal-Weight | Morgan Stanley | |
| 20.10.17 | Ericsson (Telefon L.M.Ericsson) (B) Neutral | JP Morgan Chase & Co. | |
| 20.10.17 | Volvo (B) buy | S&P Capital IQ | |
| 20.10.17 | Volvo (B) Neutral | UBS AG | |
| 20.10.17 | Volvo (B) Neutral | JP Morgan Chase & Co. | |
| 19.10.17 | Novo Nordisk Neutral | Citigroup Corp. | |
| 19.10.17 | Novo Nordisk Underweight | JP Morgan Chase & Co. | |
| 19.10.17 | Volvo (B) buy | HSBC | |
| 18.10.17 | AstraZeneca Neutral | JP Morgan Chase & Co. | |
| 17.10.17 | Novo Nordisk buy | Goldman Sachs Group Inc. | |
| 17.10.17 | AstraZeneca Sell | Goldman Sachs Group Inc. | |
| 17.10.17 | ABB (Asea Brown Boveri) Neutral | Goldman Sachs Group Inc. | |
| 17.10.17 | ABB (Asea Brown Boveri) Sell | UBS AG | |
| 17.10.17 | Novo Nordisk buy | UBS AG | |
| 17.10.17 | Volvo (B) Neutral | UBS AG | |
| 17.10.17 | Novo Nordisk Equal-Weight | Morgan Stanley | |
| 17.10.17 | Novo Nordisk Reduce | HSBC | |
| 16.10.17 | Nokia Neutral | Citigroup Corp. | |
| 16.10.17 | AstraZeneca Hold | Jefferies & Company Inc. | |
| 16.10.17 | Novo Nordisk Hold | Jefferies & Company Inc. | |
| 16.10.17 | AstraZeneca Outperform | Credit Suisse Group | |
| 13.10.17 | Novo Nordisk Underweight | JP Morgan Chase & Co. | |
| 12.10.17 | Nokia buy | UBS AG | |
| 12.10.17 | Ericsson (Telefon L.M.Ericsson) (B) Neutral | UBS AG | |
| 12.10.17 | Nokia buy | Goldman Sachs Group Inc. | |
| 11.10.17 | AstraZeneca buy | Deutsche Bank AG | |
| 11.10.17 | Ericsson (Telefon L.M.Ericsson) (B) Neutral | JP Morgan Chase & Co. | |
| 11.10.17 | ABB (Asea Brown Boveri) Hold | HSBC | |
| 10.10.17 | Nokia buy | UBS AG | |
| 10.10.17 | ABB (Asea Brown Boveri) Hold | Deutsche Bank AG | |
| 10.10.17 | Novo Nordisk Reduce | HSBC | |
| 09.10.17 | Volvo (B) Underweight | Morgan Stanley | |
| 09.10.17 | AstraZeneca Neutral | UBS AG | |
| 09.10.17 | Novo Nordisk buy | Goldman Sachs Group Inc. | |
| 09.10.17 | AstraZeneca Reduce | HSBC | |
| 06.10.17 | Fortum Neutral | JP Morgan Chase & Co. |